Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 17 |
NetGPI | no | yes: 0, no: 17 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: Q4QBQ4
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 18 |
GO:0003824 | catalytic activity | 1 | 18 |
GO:0005488 | binding | 1 | 18 |
GO:0005524 | ATP binding | 5 | 18 |
GO:0016462 | pyrophosphatase activity | 5 | 18 |
GO:0016787 | hydrolase activity | 2 | 18 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 18 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 18 |
GO:0016887 | ATP hydrolysis activity | 7 | 18 |
GO:0017076 | purine nucleotide binding | 4 | 18 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 6 | 18 |
GO:0030554 | adenyl nucleotide binding | 5 | 18 |
GO:0032553 | ribonucleotide binding | 3 | 18 |
GO:0032555 | purine ribonucleotide binding | 4 | 18 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 18 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 18 |
GO:0036094 | small molecule binding | 2 | 18 |
GO:0043167 | ion binding | 2 | 18 |
GO:0043168 | anion binding | 3 | 18 |
GO:0097159 | organic cyclic compound binding | 2 | 18 |
GO:0097367 | carbohydrate derivative binding | 2 | 18 |
GO:1901265 | nucleoside phosphate binding | 3 | 18 |
GO:1901363 | heterocyclic compound binding | 2 | 18 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 36 | 40 | PF00656 | 0.434 |
CLV_C14_Caspase3-7 | 379 | 383 | PF00656 | 0.594 |
CLV_C14_Caspase3-7 | 397 | 401 | PF00656 | 0.414 |
CLV_C14_Caspase3-7 | 471 | 475 | PF00656 | 0.701 |
CLV_C14_Caspase3-7 | 9 | 13 | PF00656 | 0.379 |
CLV_NRD_NRD_1 | 225 | 227 | PF00675 | 0.379 |
CLV_NRD_NRD_1 | 247 | 249 | PF00675 | 0.346 |
CLV_NRD_NRD_1 | 313 | 315 | PF00675 | 0.405 |
CLV_NRD_NRD_1 | 412 | 414 | PF00675 | 0.301 |
CLV_NRD_NRD_1 | 417 | 419 | PF00675 | 0.309 |
CLV_NRD_NRD_1 | 490 | 492 | PF00675 | 0.556 |
CLV_NRD_NRD_1 | 597 | 599 | PF00675 | 0.584 |
CLV_PCSK_KEX2_1 | 225 | 227 | PF00082 | 0.371 |
CLV_PCSK_KEX2_1 | 247 | 249 | PF00082 | 0.330 |
CLV_PCSK_KEX2_1 | 313 | 315 | PF00082 | 0.452 |
CLV_PCSK_KEX2_1 | 412 | 414 | PF00082 | 0.317 |
CLV_PCSK_KEX2_1 | 417 | 419 | PF00082 | 0.321 |
CLV_PCSK_KEX2_1 | 490 | 492 | PF00082 | 0.634 |
CLV_PCSK_KEX2_1 | 597 | 599 | PF00082 | 0.584 |
CLV_PCSK_PC7_1 | 413 | 419 | PF00082 | 0.329 |
CLV_PCSK_SKI1_1 | 188 | 192 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 247 | 251 | PF00082 | 0.332 |
CLV_PCSK_SKI1_1 | 266 | 270 | PF00082 | 0.311 |
CLV_PCSK_SKI1_1 | 278 | 282 | PF00082 | 0.405 |
CLV_PCSK_SKI1_1 | 300 | 304 | PF00082 | 0.368 |
CLV_PCSK_SKI1_1 | 338 | 342 | PF00082 | 0.315 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.450 |
DEG_APCC_DBOX_1 | 185 | 193 | PF00400 | 0.508 |
DEG_APCC_DBOX_1 | 570 | 578 | PF00400 | 0.564 |
DOC_ANK_TNKS_1 | 315 | 322 | PF00023 | 0.594 |
DOC_CKS1_1 | 685 | 690 | PF01111 | 0.629 |
DOC_CYCLIN_RxL_1 | 65 | 73 | PF00134 | 0.664 |
DOC_CYCLIN_yClb1_LxF_4 | 323 | 328 | PF00134 | 0.533 |
DOC_CYCLIN_yCln2_LP_2 | 55 | 61 | PF00134 | 0.308 |
DOC_MAPK_gen_1 | 287 | 297 | PF00069 | 0.666 |
DOC_MAPK_gen_1 | 386 | 395 | PF00069 | 0.543 |
DOC_MAPK_gen_1 | 564 | 574 | PF00069 | 0.564 |
DOC_MAPK_MEF2A_6 | 351 | 358 | PF00069 | 0.492 |
DOC_MAPK_MEF2A_6 | 567 | 574 | PF00069 | 0.573 |
DOC_PP1_RVXF_1 | 276 | 282 | PF00149 | 0.599 |
DOC_PP1_RVXF_1 | 323 | 329 | PF00149 | 0.531 |
DOC_SPAK_OSR1_1 | 316 | 320 | PF12202 | 0.603 |
DOC_SPAK_OSR1_1 | 567 | 571 | PF12202 | 0.618 |
DOC_SPAK_OSR1_1 | 683 | 687 | PF12202 | 0.555 |
DOC_USP7_MATH_1 | 13 | 17 | PF00917 | 0.448 |
DOC_USP7_MATH_1 | 131 | 135 | PF00917 | 0.570 |
DOC_USP7_MATH_1 | 149 | 153 | PF00917 | 0.480 |
DOC_USP7_MATH_1 | 199 | 203 | PF00917 | 0.486 |
DOC_USP7_MATH_1 | 401 | 405 | PF00917 | 0.524 |
DOC_USP7_MATH_1 | 470 | 474 | PF00917 | 0.623 |
DOC_USP7_UBL2_3 | 191 | 195 | PF12436 | 0.488 |
DOC_WW_Pin1_4 | 158 | 163 | PF00397 | 0.589 |
DOC_WW_Pin1_4 | 684 | 689 | PF00397 | 0.541 |
LIG_14-3-3_CanoR_1 | 225 | 231 | PF00244 | 0.583 |
LIG_14-3-3_CanoR_1 | 351 | 357 | PF00244 | 0.480 |
LIG_14-3-3_CanoR_1 | 422 | 429 | PF00244 | 0.526 |
LIG_14-3-3_CanoR_1 | 567 | 571 | PF00244 | 0.566 |
LIG_APCC_ABBA_1 | 250 | 255 | PF00400 | 0.602 |
LIG_APCC_ABBA_1 | 393 | 398 | PF00400 | 0.515 |
LIG_BRCT_BRCA1_1 | 133 | 137 | PF00533 | 0.507 |
LIG_CSL_BTD_1 | 196 | 199 | PF09270 | 0.433 |
LIG_EVH1_2 | 100 | 104 | PF00568 | 0.545 |
LIG_FHA_1 | 139 | 145 | PF00498 | 0.590 |
LIG_FHA_1 | 225 | 231 | PF00498 | 0.478 |
LIG_FHA_1 | 301 | 307 | PF00498 | 0.564 |
LIG_FHA_1 | 433 | 439 | PF00498 | 0.630 |
LIG_FHA_2 | 143 | 149 | PF00498 | 0.620 |
LIG_FHA_2 | 213 | 219 | PF00498 | 0.517 |
LIG_FHA_2 | 4 | 10 | PF00498 | 0.383 |
LIG_FHA_2 | 685 | 691 | PF00498 | 0.602 |
LIG_LIR_Apic_2 | 161 | 167 | PF02991 | 0.610 |
LIG_LIR_Apic_2 | 218 | 222 | PF02991 | 0.512 |
LIG_LIR_Apic_2 | 556 | 560 | PF02991 | 0.583 |
LIG_LIR_Gen_1 | 12 | 22 | PF02991 | 0.402 |
LIG_LIR_Gen_1 | 48 | 59 | PF02991 | 0.317 |
LIG_LIR_Gen_1 | 575 | 583 | PF02991 | 0.532 |
LIG_LIR_Nem_3 | 12 | 17 | PF02991 | 0.402 |
LIG_LIR_Nem_3 | 48 | 54 | PF02991 | 0.335 |
LIG_MLH1_MIPbox_1 | 133 | 137 | PF16413 | 0.507 |
LIG_NRBOX | 529 | 535 | PF00104 | 0.557 |
LIG_PCNA_PIPBox_1 | 698 | 707 | PF02747 | 0.572 |
LIG_PDZ_Class_2 | 713 | 718 | PF00595 | 0.587 |
LIG_Pex14_1 | 267 | 271 | PF04695 | 0.566 |
LIG_Pex14_2 | 292 | 296 | PF04695 | 0.531 |
LIG_Pex14_2 | 372 | 376 | PF04695 | 0.469 |
LIG_Rb_pABgroove_1 | 390 | 398 | PF01858 | 0.515 |
LIG_REV1ctd_RIR_1 | 369 | 378 | PF16727 | 0.488 |
LIG_RPA_C_Fungi | 407 | 419 | PF08784 | 0.345 |
LIG_SH2_CRK | 331 | 335 | PF00017 | 0.317 |
LIG_SH2_GRB2like | 138 | 141 | PF00017 | 0.505 |
LIG_SH2_PTP2 | 164 | 167 | PF00017 | 0.412 |
LIG_SH2_PTP2 | 51 | 54 | PF00017 | 0.348 |
LIG_SH2_STAP1 | 29 | 33 | PF00017 | 0.427 |
LIG_SH2_STAP1 | 368 | 372 | PF00017 | 0.342 |
LIG_SH2_STAT3 | 29 | 32 | PF00017 | 0.577 |
LIG_SH2_STAT3 | 682 | 685 | PF00017 | 0.479 |
LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.374 |
LIG_SH2_STAT5 | 164 | 167 | PF00017 | 0.421 |
LIG_SH2_STAT5 | 208 | 211 | PF00017 | 0.564 |
LIG_SH2_STAT5 | 284 | 287 | PF00017 | 0.485 |
LIG_SH2_STAT5 | 33 | 36 | PF00017 | 0.435 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.227 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.456 |
LIG_SH3_3 | 102 | 108 | PF00018 | 0.433 |
LIG_SH3_3 | 156 | 162 | PF00018 | 0.488 |
LIG_SH3_3 | 327 | 333 | PF00018 | 0.372 |
LIG_SH3_3 | 351 | 357 | PF00018 | 0.463 |
LIG_SH3_3 | 538 | 544 | PF00018 | 0.440 |
LIG_SH3_3 | 63 | 69 | PF00018 | 0.484 |
LIG_SH3_3 | 83 | 89 | PF00018 | 0.423 |
LIG_SH3_3 | 94 | 100 | PF00018 | 0.335 |
LIG_SUMO_SIM_anti_2 | 303 | 308 | PF11976 | 0.432 |
LIG_SUMO_SIM_par_1 | 141 | 148 | PF11976 | 0.385 |
LIG_SUMO_SIM_par_1 | 211 | 218 | PF11976 | 0.327 |
LIG_SUMO_SIM_par_1 | 547 | 553 | PF11976 | 0.405 |
LIG_TYR_ITIM | 588 | 593 | PF00017 | 0.593 |
LIG_UBA3_1 | 189 | 195 | PF00899 | 0.336 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.511 |
MOD_CK1_1 | 674 | 680 | PF00069 | 0.633 |
MOD_CK1_1 | 78 | 84 | PF00069 | 0.546 |
MOD_CK2_1 | 684 | 690 | PF00069 | 0.391 |
MOD_Cter_Amidation | 488 | 491 | PF01082 | 0.824 |
MOD_GlcNHglycan | 237 | 240 | PF01048 | 0.522 |
MOD_GlcNHglycan | 529 | 533 | PF01048 | 0.373 |
MOD_GlcNHglycan | 599 | 602 | PF01048 | 0.651 |
MOD_GlcNHglycan | 674 | 677 | PF01048 | 0.718 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.371 |
MOD_GSK3_1 | 149 | 156 | PF00069 | 0.485 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.563 |
MOD_GSK3_1 | 352 | 359 | PF00069 | 0.493 |
MOD_GSK3_1 | 41 | 48 | PF00069 | 0.635 |
MOD_GSK3_1 | 494 | 501 | PF00069 | 0.691 |
MOD_GSK3_1 | 593 | 600 | PF00069 | 0.662 |
MOD_GSK3_1 | 667 | 674 | PF00069 | 0.686 |
MOD_LATS_1 | 595 | 601 | PF00433 | 0.594 |
MOD_N-GLC_1 | 170 | 175 | PF02516 | 0.506 |
MOD_NEK2_1 | 41 | 46 | PF00069 | 0.581 |
MOD_NEK2_1 | 441 | 446 | PF00069 | 0.696 |
MOD_NEK2_1 | 528 | 533 | PF00069 | 0.479 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.535 |
MOD_NEK2_1 | 76 | 81 | PF00069 | 0.478 |
MOD_NEK2_2 | 291 | 296 | PF00069 | 0.450 |
MOD_NEK2_2 | 566 | 571 | PF00069 | 0.435 |
MOD_PIKK_1 | 703 | 709 | PF00454 | 0.431 |
MOD_PKA_1 | 597 | 603 | PF00069 | 0.611 |
MOD_PKA_2 | 224 | 230 | PF00069 | 0.439 |
MOD_PKA_2 | 421 | 427 | PF00069 | 0.377 |
MOD_PKA_2 | 566 | 572 | PF00069 | 0.456 |
MOD_PKA_2 | 597 | 603 | PF00069 | 0.698 |
MOD_PKA_2 | 712 | 718 | PF00069 | 0.511 |
MOD_Plk_1 | 217 | 223 | PF00069 | 0.500 |
MOD_Plk_1 | 300 | 306 | PF00069 | 0.484 |
MOD_Plk_2-3 | 212 | 218 | PF00069 | 0.335 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.404 |
MOD_Plk_4 | 291 | 297 | PF00069 | 0.412 |
MOD_Plk_4 | 302 | 308 | PF00069 | 0.405 |
MOD_Plk_4 | 37 | 43 | PF00069 | 0.530 |
MOD_Plk_4 | 401 | 407 | PF00069 | 0.488 |
MOD_Plk_4 | 45 | 51 | PF00069 | 0.580 |
MOD_Plk_4 | 578 | 584 | PF00069 | 0.372 |
MOD_Plk_4 | 70 | 76 | PF00069 | 0.644 |
MOD_ProDKin_1 | 158 | 164 | PF00069 | 0.473 |
MOD_ProDKin_1 | 684 | 690 | PF00069 | 0.407 |
MOD_SUMO_for_1 | 209 | 212 | PF00179 | 0.321 |
TRG_DiLeu_BaEn_1 | 185 | 190 | PF01217 | 0.359 |
TRG_DiLeu_BaEn_1 | 578 | 583 | PF01217 | 0.516 |
TRG_DiLeu_BaEn_2 | 389 | 395 | PF01217 | 0.342 |
TRG_DiLeu_BaLyEn_6 | 66 | 71 | PF01217 | 0.578 |
TRG_DiLeu_LyEn_5 | 185 | 190 | PF01217 | 0.341 |
TRG_ENDOCYTIC_2 | 368 | 371 | PF00928 | 0.317 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.445 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.264 |
TRG_ENDOCYTIC_2 | 576 | 579 | PF00928 | 0.398 |
TRG_ENDOCYTIC_2 | 590 | 593 | PF00928 | 0.444 |
TRG_ER_diArg_1 | 186 | 189 | PF00400 | 0.467 |
TRG_ER_diArg_1 | 224 | 226 | PF00400 | 0.418 |
TRG_ER_diArg_1 | 230 | 233 | PF00400 | 0.472 |
TRG_ER_diArg_1 | 246 | 248 | PF00400 | 0.416 |
TRG_ER_diArg_1 | 313 | 316 | PF00400 | 0.541 |
TRG_ER_diArg_1 | 412 | 414 | PF00400 | 0.369 |
TRG_ER_diArg_1 | 570 | 573 | PF00400 | 0.449 |
TRG_NES_CRM1_1 | 578 | 592 | PF08389 | 0.443 |
TRG_Pf-PMV_PEXEL_1 | 640 | 644 | PF00026 | 0.484 |
TRG_Pf-PMV_PEXEL_1 | 68 | 72 | PF00026 | 0.516 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P906 | Leptomonas seymouri | 31% | 98% |
A0A1X0NTT2 | Trypanosomatidae | 36% | 100% |
A0A3Q8IC80 | Leishmania donovani | 74% | 98% |
A0A3Q8IC95 | Leishmania donovani | 90% | 99% |
A0A3Q8IHZ0 | Leishmania donovani | 29% | 100% |
A0A422NUH1 | Trypanosoma rangeli | 34% | 100% |
A4HCE5 | Leishmania braziliensis | 65% | 100% |
A4HZW7 | Leishmania infantum | 91% | 100% |
A4IDZ9 | Leishmania infantum | 29% | 100% |
C9ZSJ9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
E9AU21 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
E9AVS5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 99% |
E9AVS6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 72% | 98% |
Q4Q0H4 | Leishmania major | 28% | 100% |
Q4QBQ3 | Leishmania major | 80% | 100% |
V5DMJ8 | Trypanosoma cruzi | 33% | 100% |